Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Doceree Inc.

From Wikipedia, the free encyclopedia

Doceree Inc. is an American healthcare marketing technology company headquartered in Short Hills, New Jersey.[1] Founded in 2020, the company provides programmatic messaging and point-of-care advertising platforms intended for pharmaceutical and life sciences industries.[2]

History

[edit]

Doceree Inc. was founded in 2019 by Harshit Jain.[3][4][5] The company began operations in the United States and India in 2020. Between 2020 and 2024, the company completed several financing rounds, including a seed round in 2020,[6][7] an $11 million Series A led by Eight Roads Ventures and F-Prime Capital in 2022,[8] and a $35 million Series B led by Creaegis in 2023. In June 2024, the company received an additional $13.6 million in equity funding from Creaegis.[8]

In 2022, the company expanded into the United Kingdom and Southeast Asia through a partnership with Hello Health Group. In 2023, it released a demand-side platform (DSP). By 2026, the company’s network included approximately 2,000 medical publishing platforms.[9][10]

EHR

[edit]

The company's software is integrated with electronic health record (EHR) systems.[11][12] In 2024, the United States Patent and Trademark Office granted the company a patent (No. 11,875,100) for a system that uses clinical data points to automate digital messages within medical software. The platform uses identity-resolution protocols to group healthcare professionals for advertisements.[9][10][13][14]

References

[edit]
  1. ↑ Lal, Unmesh (2026-05-29). "From Awareness to Fill: How Doceree Built Healthcare Marketing's First AI Operating System". Frost & Sullivan. Retrieved 2026-06-05.
  2. ↑ Naik, Amit Raja (2020-09-10). "Healthtech Startup Doceree Is Giving Pharma Marketing A 21st Century Digital Makeover". Inc42 Media.
  3. ↑ "UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK" (PDF). Applied Antitrust Law.
  4. ↑ Alves, Glynda (2020-11-27). "Doceree boss felt things were back to normal after scribbling brainstorming ideas on office whiteboard". The Economic Times. ISSN 0013-0389.
  5. ↑ Chowdhry, Amit (2025-02-27). "Doceree: Interview With Founder & Global CEO Dr. Harshit Jain About The Physician-Only Marketing Platform". Pulse 2.0.
  6. ↑ "Inside Doceree's Push to Own the Physician's Screen". Moneycontrol. Archived from the original on 2022-08-15.
  7. ↑ "Techcircle". Techcircle. 2020-05-12.
  8. 1 2 Manchanada, Kunal. "Doceree". entrackr.com.
  9. 1 2 Chaganti, Srinivas P. (2025-11-19). PharmaMed Press. PharmaMed Press / BSP Books. ISBN 978-93-49562-08-0.
  10. 1 2 Computer, Express (2022-08-19). "Express Computer". Express Computer.
  11. ↑ "This startup is helping pharma cos go digital to promote drugs, including Remdesivir". www.moneycontrol.com.
  12. ↑ "Doceree Inc". www.bloomberg.com.
  13. ↑ Mundhra, Laxitha. "ciol". www.ciol.com.
  14. ↑ Loeb, Stacy; Keith, Scott W.; Gross, Laura; Hartman, Rebecca L.; Beer, Tomasz M.; Brierley, Karina L.; Cheng, Heather H.; Couvillon, Anna; Dicker, Adam P.; Friedman, Sue; Gomella, Leonard G.; Karsh, Lawrence; Kelly, William K.; Lallas, Costas D.; Leader, Amy E. "Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry". JCO Precision Oncology (9): e2500571. doi:10.1200/PO-25-00571. PMC 12462908. PMID 40971753.
[edit]